Bank OZK’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11M | Buy |
11,984
+127
| +1% | +$129K | 3.89% | 2 |
|
|
2025
Q4 | $12.7M | Sell |
11,857
-441
| -4% | -$422K | 4.5% | 3 |
|
|
2025
Q3 | $9.38M | Buy |
12,298
+316
| +3% | +$235K | 3.32% | 4 |
|
|
2025
Q2 | $9.34M | Buy |
11,982
+40
| +0.3% | +$31.1K | 3.58% | 3 |
|
|
2025
Q1 | $9.86M | Buy |
11,942
+552
| +5% | +$459K | 4.1% | 3 |
|
|
2024
Q4 | $8.79M | Buy |
11,390
+92
| +0.8% | +$76.2K | 3.65% | 3 |
|
|
2024
Q3 | $10M | Sell |
11,298
-324
| -3% | -$291K | 4.14% | 3 |
|
|
2024
Q2 | $10.5M | Buy |
11,622
+78
| +0.7% | +$62.4K | 4.55% | 3 |
|
|
2024
Q1 | $8.98M | Sell |
11,544
-257
| -2% | -$183K | 4.02% | 3 |
|
|
2023
Q4 | $6.88M | Sell |
11,801
-451
| -4% | -$263K | 3.36% | 3 |
|
|
2023
Q3 | $6.58M | Sell |
12,252
-407
| -3% | -$210K | 3.61% | 3 |
|
|
2023
Q2 | $5.94M | Sell |
12,659
-639
| -5% | -$268K | 2.83% | 3 |
|
|
2023
Q1 | $4.57M | Sell |
13,298
-82
| -0.6% | -$27.7K | 2.27% | 8 |
|
|
2022
Q4 | $4.89M | Sell |
13,380
-103
| -0.8% | -$36.5K | 2.42% | 6 |
|
|
2022
Q3 | $4.36M | Buy |
13,483
+120
| +0.9% | +$38K | 2.37% | 6 |
|
|
2022
Q2 | $4.33M | Sell |
13,363
-387
| -3% | -$116K | 2.19% | 7 |
|
|
2022
Q1 | $3.94M | Sell |
13,750
-356
| -3% | -$91.6K | 1.69% | 17 |
|
|
2021
Q4 | $3.9M | Sell |
14,106
-149
| -1% | -$37.8K | 1.59% | 17 |
|
|
2021
Q3 | $3.29M | Sell |
14,255
-131
| -0.9% | -$32.3K | 1.49% | 20 |
|
|
2021
Q2 | $3.3M | Sell |
14,386
-592
| -4% | -$119K | 1.46% | 22 |
|
|
2021
Q1 | $2.8M | Sell |
14,978
-630
| -4% | -$123K | 1.29% | 27 |
|
|
2020
Q4 | $2.63M | Sell |
15,608
-33
| -0.2% | -$4.93K | 1.3% | 25 |
|
|
2020
Q3 | $2.31M | Sell |
15,641
-32
| -0.2% | -$4.95K | 1.24% | 27 |
|
|
2020
Q2 | $2.57M | Buy |
15,673
+200
| +1% | +$30.7K | 1.46% | 21 |
|
|
2020
Q1 | $2.15M | Buy |
15,473
+1,030
| +7% | +$142K | 1.18% | 23 |
|
|
2019
Q4 | $1.9M | Buy |
14,443
+765
| +6% | +$88.7K | 0.75% | 37 |
|
|
2019
Q3 | $1.53M | Buy |
13,678
+1,290
| +10% | +$144K | 0.67% | 41 |
|
|
2019
Q2 | $1.37M | Buy |
12,388
+350
| +3% | +$41.2K | 0.6% | 47 |
|
|
2019
Q1 | $1.56M | Buy |
12,038
+905
| +8% | +$110K | 0.68% | 44 |
|
|
2018
Q4 | $1.29M | Buy |
11,133
+171
| +2% | +$19.1K | 0.65% | 47 |
|
|
2018
Q3 | $1.18M | Sell |
10,962
-981
| -8% | -$98.1K | 0.47% | 54 |
|
|
2018
Q2 | $1.02M | Buy |
11,943
+821
| +7% | +$67.4K | 0.4% | 55 |
|
|
2018
Q1 | $861K | Buy |
11,122
+1,075
| +11% | +$86.5K | 0.34% | 65 |
|
|
2017
Q4 | $849K | Sell |
10,047
-21
| -0.2% | -$1.79K | 0.32% | 71 |
|
|
2017
Q3 | $861K | Buy |
10,068
+1,535
| +18% | +$126K | 0.36% | 63 |
|
|
2017
Q2 | $702K | Sell |
8,533
-190
| -2% | -$15.5K | 0.25% | 77 |
|
|
2017
Q1 | $734K | Buy |
8,723
+1,740
| +25% | +$139K | 0.24% | 72 |
|
|
2016
Q4 | $513K | Sell |
6,983
-23
| -0.3% | -$1.71K | 0.17% | 83 |
|
|
2016
Q3 | $562K | Hold |
7,006
| – | – | 0.2% | 74 |
|
|
2016
Q2 | $552K | Hold |
7,006
| – | – | 0.2% | 75 |
|
|
2016
Q1 | $504K | Sell |
7,006
-419
| -6% | -$31.7K | 0.18% | 80 |
|
|
2015
Q4 | $626K | Sell |
7,425
-999
| -12% | -$82.9K | 0.22% | 63 |
|
|
2015
Q3 | $705K | Sell |
8,424
-326
| -4% | -$27.5K | 0.27% | 54 |
|
|
2015
Q2 | $731K | Sell |
8,750
-95
| -1% | -$7.24K | 0.25% | 54 |
|
|
2015
Q1 | $643K | Buy |
8,845
+35
| +0.4% | +$2.49K | 0.23% | 59 |
|
|
2014
Q4 | $607K | Sell |
8,810
-535
| -6% | -$36.1K | 0.21% | 58 |
|
|
2014
Q3 | $606K | Sell |
9,345
-5,030
| -35% | -$318K | 0.23% | 56 |
|
|
2014
Q2 | $894K | Sell |
14,375
-805
| -5% | -$48K | 0.31% | 40 |
|
|
2014
Q1 | $894K | Sell |
15,180
-205
| -1% | -$11.4K | 0.32% | 40 |
|
|
2013
Q4 | $784K | Buy |
15,385
+615
| +4% | +$30.8K | 0.3% | 46 |
|
|
2013
Q3 | $744K | Buy |
14,770
+8,845
| +149% | +$463K | 0.32% | 39 |
|
|
2013
Q2 | $291K | Buy |
+5,925
| New | +$322K | 0.21% | 40 |
|
Other funds holding LLY
VCM
VPM
Bank OZK's LLY Position: Q1 2026 in Review
Bank OZK increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $129K and bringing the position to 11,984 shares worth $11M. The position accounts for 3.89% of the portfolio, ranked #2.
Bank OZK first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.7M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Bank OZK held 11,984 shares of Eli Lilly worth $11M as of Q1 2026.
- Bank OZK bought 127 Eli Lilly shares in Q1 2026, an estimated $129K.
- Eli Lilly made up 3.89% of Bank OZK's portfolio in Q1 2026, its #2 holding.
- Bank OZK first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Bank OZK's Eli Lilly position peaked at $12.7M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Bank OZK's 13F filing for Q1 2026, filed 13 May 2026.